|Original language||English (US)|
|Journal||American journal of ophthalmology|
|State||Published - Apr 2011|
ASJC Scopus subject areas
Access to Document
Other files and links
Health care reform and graduate medical education in ophthalmology. / Parrish, Richard K.; Mladenovic, Jeanette; Gedde, Steven J.In: American journal of ophthalmology, Vol. 151, No. 4, 04.2011, p. 572-574.e1.
Research output: Contribution to journal › Editorial › peer-review
TY - JOUR
T1 - Health care reform and graduate medical education in ophthalmology
AU - Parrish, Richard K.
AU - Mladenovic, Jeanette
AU - Gedde, Steven J.
N1 - Funding Information: Of the federal programs that support Accreditation Council of Graduate Medical Education (ACGME)-sponsored residencies, the Center for Medicare and Medicaid Services of the Health and Human Services (CMS/HHS) contributes the most. Medicare underwrote $9.5 billion for the training of 100 000 residents in 2008: $3 billion in direct graduate medical education payments to partially support resident salaries and $6.5 billion for indirect medical education, a calculated value based on the additional costs of patient care associated with training. 1 Based on the San Francisco Ophthalmology Residency Match for years 2007 to 2009, approximately 1363 residents filled positions at 115 programs. 2 Assuming ophthalmology represents 1.4% of all residents, the cost for their training is approximately $131 million, based on cost of the Medicare budget. This does not include funding supported by the Department of Defense or the Department of Veterans Affairs. Funding Information: Publication of this article was supported by Funding from Research to Prevent Blindness , New York, New York; Strobis Glaucoma Foundation, Inc , Boca Raton, Florida; and National Eye Institute , Bethesda, Maryland. Dr Parrish has been a member of the Scientific Advisory Boards of Alimera Sciences, Inc; Allergan, Inc; Bausch & Lomb, Inc; Danube Pharmaceuticals, Inc; Glaukos Corporation; Merck & Co, Inc; Othera Pharmaceuticals, Inc; Pfizer, Inc; Sirion Therapeutics, Inc; and Vitreoretinal Technologies, Inc. Dr Parrish has received lecture fees from Alcon Laboratories, Inc, and Pfizer, Inc. Dr Gedde has received support from Abbott Medical Optics, Inc , Abbott Park, Illinois, for the Tube versus Trabeculectomy Study and the Primary Tube versus Trabeculectomy Study. Dr Gedde has received lecture fees from Lumenis, Inc, and is a consultant for Allergan, Inc. Involved in design of the study (R.K.P., J.M., S.J.G.); conduct of the study (R.K.P., J.M., S.J.G.); collection, management, analysis, and interpretation of the data (R.K.P., J.M., S.J.G.); and preparation, review, and approval of the manuscript (R.K.P., J.M., S.J.G.). Copyright: Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2011/4
Y1 - 2011/4
UR - http://www.scopus.com/inward/record.url?scp=79952919339&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952919339&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2010.10.017
DO - 10.1016/j.ajo.2010.10.017
M3 - Editorial
C2 - 21420521
AN - SCOPUS:79952919339
SN - 0002-9394
VL - 151
SP - 572-574.e1
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
IS - 4